Valeant plays down break-up but considers name change
Drugmaker reaffirms full-year profit target as third-quarter beats expectations
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Profits and Losses